摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-chloro-1-phenyl-1,3-dihydro-2H-benzimidazol-2-one | 79759-47-0

中文名称
——
中文别名
——
英文名称
5-chloro-1-phenyl-1,3-dihydro-2H-benzimidazol-2-one
英文别名
5-chloro-1-phenyl-1H-benzo[d]imidazol-2(3H)-one;6-chloro-3-phenyl-1H-benzimidazol-2-one
5-chloro-1-phenyl-1,3-dihydro-2H-benzimidazol-2-one化学式
CAS
79759-47-0
化学式
C13H9ClN2O
mdl
——
分子量
244.68
InChiKey
RMPWZHBFXOLXFG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    223-225 °C(Solv: ethanol (64-17-5))
  • 密度:
    1.372±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    1

SDS

SDS:0d47ea85dcc4de57ddc606e2978d7789
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists
    摘要:
    In an effort to identify novel ligands possessing high affinity and selectivity for the A(2B) AR subtype, we further investigated the class of 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones V, previously disclosed by us as selective A(1) AR antagonists. Preliminary assays on a number of triazinobenzimidazoles derived from our "in-house" collection revealed that all the derivatives selected showed significant affinity at A(2B) AR, no affinity at A(3) AR, and various degrees of selectivity toward A(1) and A(2A) ARs. Investigation of a new series featuring modified substituents at the 10-position (4'-chlorophenyl or phenylethyl groups), and a chlorine atom at the 7-position (X) of the triazinobenzimidazole nucleus, yielded highly potent and selective A(2B) AR antagonists. The presence of a pendant 3-phenyl ring appears to hamper the interaction with A(2A) AR, conferring high A(2B)/A(2A) AR selectivity. Derivative 13 (X = Cl, R = C6H5) is the most potent and selective compound, with an IC50 of 3.10 nM at A(2B) AR and no affinity at A(1), A(2A), and A(3) ARs.
    DOI:
    10.1021/jm201177b
  • 作为产物:
    描述:
    (5-氯-2-(苯基氨基)苯基)氨基甲酸乙酯 在 sodium ethanolate 作用下, 以 乙醇 为溶剂, 反应 3.0h, 以99%的产率得到5-chloro-1-phenyl-1,3-dihydro-2H-benzimidazol-2-one
    参考文献:
    名称:
    Bianchi; Butti; Rossi, European Journal of Medicinal Chemistry, 1981, vol. 16, # 4, p. 321 - 326
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
    申请人:Burnham Institute for Medical Research
    公开号:EP2433496A1
    公开(公告)日:2012-03-28
    Disclosed herein are compounds that are tissue-nonspecific alkaline phosphatase inhibitors. The disclosed compounds are used to treat, prevent, or abate vascular calcification, arterial calcification and other cardiovascular diseases.
    本文公开的化合物是组织非特异性碱性磷酸酶抑制剂。所公开的化合物可用于治疗、预防或减轻血管钙化、动脉钙化和其他心血管疾病。
  • 3-Aryl-[1,2,4]triazino[4,3-<i>a</i>]benzimidazol-4(10<i>H</i>)-one: A Novel Template for the Design of Highly Selective A<sub>2B</sub> Adenosine Receptor Antagonists
    作者:Sabrina Taliani、Isabella Pugliesi、Elisabetta Barresi、Francesca Simorini、Silvia Salerno、Concettina La Motta、Anna Maria Marini、Barbara Cosimelli、Sandro Cosconati、Salvatore Di Maro、Luciana Marinelli、Simona Daniele、Maria Letizia Trincavelli、Giovanni Greco、Ettore Novellino、Claudia Martini、Federico Da Settimo
    DOI:10.1021/jm201177b
    日期:2012.2.23
    In an effort to identify novel ligands possessing high affinity and selectivity for the A(2B) AR subtype, we further investigated the class of 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones V, previously disclosed by us as selective A(1) AR antagonists. Preliminary assays on a number of triazinobenzimidazoles derived from our "in-house" collection revealed that all the derivatives selected showed significant affinity at A(2B) AR, no affinity at A(3) AR, and various degrees of selectivity toward A(1) and A(2A) ARs. Investigation of a new series featuring modified substituents at the 10-position (4'-chlorophenyl or phenylethyl groups), and a chlorine atom at the 7-position (X) of the triazinobenzimidazole nucleus, yielded highly potent and selective A(2B) AR antagonists. The presence of a pendant 3-phenyl ring appears to hamper the interaction with A(2A) AR, conferring high A(2B)/A(2A) AR selectivity. Derivative 13 (X = Cl, R = C6H5) is the most potent and selective compound, with an IC50 of 3.10 nM at A(2B) AR and no affinity at A(1), A(2A), and A(3) ARs.
  • BIANCHI, M.;BUTTI, A.;ROSSI, S.;BARZAGHI, F.;MARCARIA, V., EUR. J. MED. CHEM.-CHIM. THER., 1981, 16, N 4, 321-326
    作者:BIANCHI, M.、BUTTI, A.、ROSSI, S.、BARZAGHI, F.、MARCARIA, V.
    DOI:——
    日期:——
  • TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE INHIBITORS AND USES THEREOF FOR TREATING VASCULAR CALCIFICATION
    申请人:The Burnham Institute for Medical Research
    公开号:EP2164329A2
    公开(公告)日:2010-03-24
  • US8119693B2
    申请人:——
    公开号:US8119693B2
    公开(公告)日:2012-02-21
查看更多